3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tongue Neoplasms
1
Interventions
pembrolizumab
3
Drug Therapy
3
Vincristine
2
S 1 (combination)
2
Nivolumab
2
Gemcitabine
2
Cyclophosphamide
2
CA-4948
2
Bevacizumab
2
zimberelimab
1
venetoclax
1
tivozanib
1
titanium silicide
1
tisagenlecleucel
1
sotigalimab
1
propranolol CR
1
prednylidene
1
pimonidazole
1
palbociclib
1
mirdametinib
1
imisopasem manganese
1
gusacitinib
1
fludarabine
1
deltacortene
1
brincidofovir
1
axicabtagene ciloleucel
1
atezolizumab
1
Testosterone Propionate
1
Testosterone
1
Temozolomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Suspended
×
pimonidazole
×
Clear all
NCT03181035
2024-08-12
FAITH
Sunnybrook Health Sciences Centre
Phase 1/2
Suspended
10 enrolled